| Names | |
|---|---|
| IUPAC name
6,7-dimethyl-5-nitro-1,4-dihydroquinoxaline-2,3-dione | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C10H9N3O4 | |
| Molar mass | 235.199 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
ACEA-1328 is an NMDA receptor antagonist.
ACEA-1328 acts as an antagonist of the glycine site at the NMDA receptor.
A study on mice has shown that ACEA-1328 was able to increase the analgesic action of morphine. It was also shown that it can reduce the formation of tolerance to morphine.
ACEA-1328 (along with other drugs) has been shown to be able to reduce convulsions induced by a cocaine overdose.